Researchers Discover Gene That Helps Control the Production of Stomach Acid
This data is published in the Proceedings of the National Academy of Sciences (PNAS).
UC professor Manoocher Soleimani, MD, and colleagues found that when transporter Slc26a9the gene responsible for the production of chloride in the stomachis eliminated from the mouse models system, acid secretion in the stomach stops.
Gastric acid, comprised mainly of hydrochloric acid (HCL), is the main secretion in the stomach and helps the body to break down and digest food.
Investigators were already aware of the gene that caused hydrogen to secrete in the stomach, but the gene that caused chloride to secrete has remained an unknown, Soleimani says. When we knocked outor eliminatedthis specific transporter in mouse models, acid secretion in the stomach completely halted.
The hydrogen and chloride genes must work together in order for the stomach to produce acid and function normally.
Soleimani, director of UCs nephrology division and principal investigator of the study, hopes that this data can help researchers create more therapies for people who overproduce stomach acid.
A very large number of people have acid refluxcaused by regurgitation of stomach acid into the esophagusor peptic ulcerscaused by the passing of excess stomach acid into the small intestine, Soleimani says. This occurs because of overproduction of acid in the stomach, and current medications that help control this condition cause undesirable side effects.
He adds that long-term use of these kinds of drugs could cause damage to the lining of the stomach, among other problems.
With this information, we hope to one day be able to administer gene therapies to patients and avoid this painful and damaging problem altogether, he says.
Coauthors include researchers from the Cincinnati Veterans Affairs Medical Center; the University of Hannover, Germany; the Centre National de la Recherche Scientifique/Universite de Nice Sophia Antipolis, France; Harvard University Medical School, Boston; and the University of California, Berkeley.
This study was funded in part by the National Institutes of Health and by a Merit Review grant from the U.S. Department of Veteran Affairs.
Tags
Related Stories
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.
Cancer Center director charts future based on collaboration, AI
August 10, 2026
David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.
Bidirectional link between oral, kidney health calls for patient education, access
August 4, 2026
Despite growing awareness of the connection between oral health and chronic health conditions, patient awareness and access to dental care remain limited, according to University of Cincinnati experts who recently spoke with Healio | Nephrology News & Issues.